Generic Times Product News

Pharmacy Times, Volume 0, 0

Claravis (isotretinoin capsules USP, 30 mg)

Marketed by:Barr Laboratories Inc, a subsidiary of BarrPharmaceuticals Inc (Woodcliff Lake, NJ)

Compared to:Claravis capsules 30 mg will compete withRanbaxy's Sotret (isotretinoin) Capsules USP 30 mg.

Indication:May 12, 2006—Barr Laboratories received FDAapproval to manufacture and market isotretinoin capsules,30 mg, under the trade name Claravis. With theapproval for this strength, the company will now marketthe full line of isotretinoin product strengths.Claravis is indicated for the treatment of severe recalcitrantnodular acne.

Dosage Form:Capsules: 10, 20, 30, and 40 mg

For More Information:www.barrlabs.com

Metronidazole Lotion 0.75%

Marketed by:Fougera, a division ofALTANA Inc(Melville, NY)

Compared to:MetroLotion (Galderma)

Indication:May 24, 2006—Fougeraannounced that it was first to market with metronidazolelotion 0.75%. It was approved by the FDA and isindicated for the treatment of rosacea. The lotion isavailable in a 59-mL bottle.

Dosage Form:Lotion: 59-mL bottle

For More Information:www.fougera.com800-645-9833

Polyethylene Glycol 3350, NF Powder for Oral Solution

Marketed by:Paddock Laboratories Inc(Minneapolis, Minn)

Compared to:MiraLax(Braintree Laboratories Inc)

Indication:May 2006—Paddock Laboratories announced the introductionof Polyethylene Glycol 3350, NF Powder forOral Solution. It is an osmotic agent that causes waterto be retained with the stool and is indicated for thetreatment of occasional constipation.

Dosage Form:255-and 527-g bottles

For More Information:www.paddocklabs.com800-328-5113

Probenecid Tablets 500 mg, USP

Marketed by:Lannett Co Inc (Philadelphia, Pa)

Compared to:Benemid Tablets (Merck & Co Inc)

Indication:May 22, 2006—Lannett Co Inc received FDA approvalfor probenecid tablets 500 mg, USP. The product is indicatedfor the treatment of hyperuricemia associatedwith gout and gouty arthritis. It is also used as adjunctivetherapy with some antibiotics such as penicillin,ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, forelevation and prolongation of plasma levels by whateverroute the antibiotic is given.

Dosage Form:Tablets: 500 mg

For More Information:www.lannett.com

Urea 35% Lotion

Marketed by:Glades Pharmaceuticals, LLC, awholly owned subsidiary of StiefelLaboratories (Duluth, Ga)

Compared to:Keralac Lotion (DoakDermatologics, a subsidiary ofBradley Pharmaceuticals Inc)

Indication:May 15, 2006—GladesPharmaceuticals announced theaddition of Urea 35% Lotion, with the same activeingredient as Keralac Lotion, to its efficacious line ofurea-based keratolytic agents. This new addition willjoin the company's line of Urea 40% Cream, Gel, andLotion products. It is an effective treatment option forhyperkeratotic conditions, including dry, rough skin,dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis,keratoderma, corns, and calluses.

Dosage Form:Lotion: 207-and 325-mL bottles

For More Information:www.glades.com